1 April 2025 false No description of principal activity Taxfiler 2024.6 08021633business:PrivateLimitedCompanyLtd2025-04-012026-03-31 080216332025-03-31 080216332025-04-012026-03-31 08021633business:AuditExempt-NoAccountantsReport2025-04-012026-03-31 08021633business:FilletedAccounts2025-04-012026-03-31 080216332026-03-31 08021633business:Director12025-04-012026-03-31 08021633business:Director22025-04-012026-03-31 08021633business:RegisteredOffice2025-04-012026-03-31 080216332025-03-31 08021633core:WithinOneYear2026-03-31 08021633core:WithinOneYear2025-03-31 08021633core:ShareCapitalcore:PreviouslyStatedAmount2026-03-31 08021633core:ShareCapitalcore:PreviouslyStatedAmount2025-03-31 08021633core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2026-03-31 08021633core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-03-31 08021633core:PreviouslyStatedAmount2026-03-31 08021633core:PreviouslyStatedAmount2025-03-31 08021633business:SmallEntities2025-04-012026-03-31 08021633countries:EnglandWales2025-04-012026-03-31 08021633core:PlantMachinery2025-04-012026-03-31 08021633core:ComputerEquipment2025-04-012026-03-31 08021633core:OtherPropertyPlantEquipment2025-04-012026-03-31 08021633core:PlantMachinery2025-03-31 08021633core:ComputerEquipment2025-03-31 08021633core:PlantMachinery2026-03-31 08021633core:ComputerEquipment2026-03-31 080216332024-04-012025-03-31 iso4217:GBP xbrli:pure
Company Registration No. 08021633 (England and Wales)
QX Medical Limited Unaudited accounts for the year ended 31 March 2026
QX Medical Limited Unaudited accounts Contents
Page
- 2 -
QX Medical Limited Company Information for the year ended 31 March 2026
Directors
Dr Qian Xu Qian Xu
Company Number
08021633 (England and Wales)
Registered Office
402a Streatham High Road London SW16 3SN United Kingdom
Accountants
Yukimi Rabnott FCPFA for and on behalf of On The Spot Trading Name of Carson Rabnott Limited EC2Y 8DR
- 3 -
QX Medical Limited Statement of financial position as at 31 March 2026
2026 
2025 
Notes
£ 
£ 
Fixed assets
Tangible assets
2,903 
4,617 
Current assets
Debtors
70,240 
50,430 
Cash at bank and in hand
50,173 
20,290 
120,413 
70,720 
Creditors: amounts falling due within one year
(34,025)
(25,854)
Net current assets
86,388 
44,866 
Net assets
89,291 
49,483 
Capital and reserves
Called up share capital
1 
1 
Profit and loss account
89,290 
49,482 
Shareholders' funds
89,291 
49,483 
For the year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 27 August 2026 and were signed on its behalf by
Dr Qian Xu Director Company Registration No. 08021633
- 4 -
QX Medical Limited Notes to the Accounts for the year ended 31 March 2026
1
Statutory information
QX Medical Limited is a private company, limited by shares, registered in England and Wales, registration number 08021633. The registered office is 402a Streatham High Road, London, SW16 3SN, United Kingdom.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Revenue recognition
Revenue, described as turnover, is the value of goods (net of VAT) provided to customers during the year, plus the value of work (net of VAT) performed during the year with respect to services. Revenue is recognised on the sale of goods when the goods are delivered and title has passed. Revenue is recognised on the provision of services on a percentage degree of completion basis calculated by reference to the time expended compared to the total anticipated time.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
three years
Computer equipment
three years
Other tangible fixed assets
five years
Pension costs
The company operates a defined contribution scheme. The assets of the scheme are held separately from those of the company in independently administered funds. The pension costs charge represents contributions payable for the period by the company to the fund.
4
Tangible fixed assets
Plant & machinery 
Computer equipment 
Total 
£ 
£ 
£ 
Cost or valuation
At cost 
At cost 
At 1 April 2025
6,631 
899 
7,530 
At 31 March 2026
6,631 
899 
7,530 
Depreciation
At 1 April 2025
2,838 
75 
2,913 
Charge for the year
462 
1,252 
1,714 
At 31 March 2026
3,300 
1,327 
4,627 
Net book value
At 31 March 2026
3,331 
(428)
2,903 
At 31 March 2025
3,793 
824 
4,617 
- 5 -
QX Medical Limited Notes to the Accounts for the year ended 31 March 2026
5
Debtors
2026 
2025 
£ 
£ 
Amounts falling due within one year
Trade debtors
3,516 
- 
Accrued income and prepayments
1,584 
825 
Other debtors
65,140 
49,605 
70,240 
50,430 
6
Creditors: amounts falling due within one year
2026 
2025 
£ 
£ 
Taxes and social security
31,689 
24,615 
Loans from directors
1,098 
31 
Accruals
1,238 
1,208 
34,025 
25,854 
7
Transactions with related parties
There were no material transactions with directors and shareholders that were not conducted under normal market conditions. The amounts owed to the directors are included within creditors. No interest is charged.
8
Average number of employees
During the year the average number of employees was 0 (2025: 0).
- 6 -